Navigation Links
India's Asthma Drug Market Will Exceed $400 Million in 2014
Date:12/7/2010

BURLINGTON, Mass., Dec. 7, 2010 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that India's asthma drug market will grow from $246 million in 2009 to $403 million in 2014, representing an annual growth rate of ten percent. According to the Emerging Markets report entitled Asthma in India, this growth will be fueled by improved access to medical care, a growing drug-treated population and a rising number of higher-income, brand-conscious asthma patients demanding more-efficacious agents.  

"At $246 million, India's asthma market is close to some European Union countries in dollar terms," said Decision Resources Analyst Manashi Sherawat, M.Sc., Ph.D. "In 2009, multinational pharmaceutical companies accounted for five percent of total sales in the Indian asthma market and while uptake of Western-branded asthma drugs will increase by 2014, these drugs will face fierce competition from less-expensive Indian brands and generics."

According to the report, fixed-dosed combination drugs represent a major opportunity for multinational pharmaceutical companies. The use of combination therapy as maintenance treatment will increase as medical practice in India shifts from treating asthma on an as-needed basis toward treating it as a chronic disease that requires maintenance treatment. Specifically, Indian specialists anticipate that fixed-dosed combination therapies such as long-acting beta(2) agonist (LABA)/inhaled corticosteroid (ICS) will experience the highest uptake.

"Indian specialists struggle with patient compliance when treating asthma. The importance of consistent maintenance therapy is paramount because improved disease outcomes are not achieved unless maintenance therapies are administered consistently. The Indian asthma market would benefit from new, more-convenient therapies, which would boost patient compliance," added Dr. Sherawat.

The new report features extensive primary research of Indian specialists as well as epidemiology data.

About Emerging Markets ReportsDecision Resources is the FIRST and ONLY company to offer a syndicated report series for high-growth emerging markets with comprehensive disease-specific analysis. Each report assesses the commercial opportunity in the pharmaceutical market for a disease based on population demographics, economic development, disease epidemiology and changing physicians' practices.

About Decision ResourcesDecision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:Decision ResourcesLisa Osgood781-993-2606losgood@dresources.comDecision Resources, Inc.Christopher Comfort781-993-2597ccomfort@dresources.com
'/>"/>

SOURCE Decision Resources
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Study: Overuse of Combination Drug Therapy in Patients with Mild Asthma Leads to Increased Costs
2. Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology
3. Boston Scientific Completes Acquisition of Asthmatx
4. Due to Rising Costs of Asthma and Chronic Obstructive Pulmonary Disease Drugs, Managed Care Organization Pharmacy Directors Will be Forced to Tighten Their Formularies
5. Lexiscan® (Regadenoson) Injection Study in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (COPD) Presented as Late-Breaker at American Society of Nuclear Cardiology 2010
6. Boston Scientific to Acquire Asthmatx
7. MAP Pharmaceuticals Announces All Non-Asthmatic Patients Complete Treatment in Open-Label Trial and Completion of Treatment in QT Trial for LEVADEX™ Clinical Program
8. FDAs New Safety Controls for LABA-Containing Drugs Will Impact Prescribing of Single-Agent ICS and LABA/ICS Combination Therapies for the Treatment of Asthma
9. Latina Actress and Author Dayanara Torres Launches Online Asthma Education Resource for Hispanic Community in Partnership with Merck and AAFA
10. Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations
11. Teva Respiratory to Host Phillies Asthma Awareness Night Featuring Free Asthma and Exercise-Induced Bronchospasm Screenings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... May 24, 2016  Joe Marziani has joined VMS BioMarketing as senior vice president ... today. In his new role, Marziani will lead the company,s business development and sales ... improve outcomes. Photo - http://photos.prnewswire.com/prnh/20160523/371089 ... ... ...
(Date:5/24/2016)... May 24, 2016 Open Access ... Clinical Neurophysiology  Elsevier , a world-leading ... services, today announced the launch of Clinical ... journal that focuses on clinical practice issues in clinical ... clinical series, normal values and didactic reviews. It is ...
(Date:5/23/2016)... 2016 Global Paclitaxel Market 2016 ... 12 companies and the Paclitaxel analysis in this study ... industry and its players. This is the ... details the current state of the industry while providing ... applications and industry chain structure. The Paclitaxel market analysis ...
Breaking Medicine Technology:
(Date:5/24/2016)... ... 2016 , ... Jericho Project has named LaToya Williams-Belfort to the position of ... fundraising and communications for the nationally-acclaimed nonprofit, working closely with CEO Tori Lyon and ... homelessness at its roots. , “LaToya Williams-Belfort is joining Jericho at an exciting ...
(Date:5/24/2016)... ... May 24, 2016 , ... Local engineering firm, ... Virginia Medical Center located in Woodbridge, VA. The project includes a brand ... single site. , The new 2 story building houses the Central Sterile department, ...
(Date:5/24/2016)... ... May 24, 2016 , ... Regenerative Medicine is being transformed by ongoing ... therapy technology, protocols and patient results as have been achieved with Okyanos Cell ... accessible standard of care for patients worldwide. , As the Medical Advisory Chairman at ...
(Date:5/24/2016)... ... May 24, 2016 , ... Boyd Industries, a leading supplier of ... groundbreaking new product for pediatric dentistry , at AAPD 2016, the annual conference ... May 26-29. The Concealed Delivery Unit keeps dental hand pieces and other anxiety-provoking pieces ...
(Date:5/24/2016)... ... May 24, 2016 , ... Growing in popularity, more and more people ... are available and easily accessible. Whether someone chooses to cut gluten out of their ... diet, King Kullen Grocery stocks their shelves with many different gluten-free products all year ...
Breaking Medicine News(10 mins):